Literature DB >> 20496212

Methods of robust design of nonlinear models with an application to pharmacokinetics.

Lee-Kien Foo1, Stephen Duffull.   

Abstract

Optimal design methods for nonlinear models are dependent on the true but unknown parameter values. Criteria for developing designs that are robust to the choice of parameter values such as ED optimality have been proposed. However, these criteria are computationally intensive and can perform poorly at extremes of the prior parameter distribution. Two different criteria are proposed. Both involve evaluation of the determinant of the Fisher information matrix over models formed at various combinations of the 2.5th and 97.5th percentiles of the parameter space. The performance of the proposed optimality criteria is compared to two existing robust optimal design criteria.

Mesh:

Substances:

Year:  2010        PMID: 20496212     DOI: 10.1080/10543401003618918

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  6 in total

1.  Adaptive optimal design for bridging studies with an application to population pharmacokinetic studies.

Authors:  Lee Kien Foo; Stephen Duffull
Journal:  Pharm Res       Date:  2012-02-14       Impact factor: 4.200

2.  Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments.

Authors:  Holger Dette; Andrey Pepelyshev; Weng Kee Wong
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-05-22       Impact factor: 2.745

3.  Prediction of shrinkage of individual parameters using the bayesian information matrix in non-linear mixed effect models with evaluation in pharmacokinetics.

Authors:  François Pierre Combes; Sylvie Retout; Nicolas Frey; France Mentré
Journal:  Pharm Res       Date:  2013-06-07       Impact factor: 4.200

4.  Influence of the Size of Cohorts in Adaptive Design for Nonlinear Mixed Effects Models: An Evaluation by Simulation for a Pharmacokinetic and Pharmacodynamic Model for a Biomarker in Oncology.

Authors:  Giulia Lestini; Cyrielle Dumont; France Mentré
Journal:  Pharm Res       Date:  2015-06-30       Impact factor: 4.200

5.  Assessing robustness of designs for random effects parameters for nonlinear mixed-effects models.

Authors:  Stephen B Duffull; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-10-24       Impact factor: 2.745

6.  Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.

Authors:  Kris M Jamsen; Stephen B Duffull; Joel Tarning; Niklas Lindegardh; Nicholas J White; Julie A Simpson
Journal:  Malar J       Date:  2011-07-01       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.